𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical aspects of epidermal growth factor receptor inhibitors: Benefit and risk

✍ Scribed by Tefurumi KATO; Kazuto NISHIO


Book ID
108964542
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
94 KB
Volume
11
Category
Article
ISSN
1323-7799

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Clinical implications of the mechanism o
✍ John Marshall πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 189 KB πŸ‘ 2 views

## Abstract Novel therapeutic agents that target the epidermal growth factor receptor (EGFR) constitute an important addition to the therapeutic armamentarium for the treatment of metastatic disease. EGFR‐targeted agents currently approved by the U.S. Food and Drug Administration include cetuximab,